This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Cyclin 3D structures
From Proteopedia
(Difference between revisions)
| Line 10: | Line 10: | ||
**[[3my5]], [[2wpa]], [[2wxv]], [[2wih]], [[2wip]], [[3f5x]], [[3eoc]], [[3eid]], [[3ej1]], [[3dog]], [[3ddp]], [[3ddq]], [[3bht]], [[2v22]], [[2uue]], [[2i40]], [[2bkz]], [[2c5n]], [[2c5o]], [[2c5v]], [[2c5x]], [[2c5y]], [[2bpm]], [[2c4g]], [[1fvv]], [[2c6t]] – hCYCA2 +CDK2+inhibitor <br /> | **[[3my5]], [[2wpa]], [[2wxv]], [[2wih]], [[2wip]], [[3f5x]], [[3eoc]], [[3eid]], [[3ej1]], [[3dog]], [[3ddp]], [[3ddq]], [[3bht]], [[2v22]], [[2uue]], [[2i40]], [[2bkz]], [[2c5n]], [[2c5o]], [[2c5v]], [[2c5x]], [[2c5y]], [[2bpm]], [[2c4g]], [[1fvv]], [[2c6t]] – hCYCA2 +CDK2+inhibitor <br /> | ||
| - | **[[3bhu]], [[3bhv]], [[2uzd]], [[2uzb]], [[2uze]], [[2uzl]], [[2uzn]], [[2uzo]], [[2iw6]], [[2iw8]], [[2iw9]], [[2g9x]], [[1oi9]], [[1oiu]], [[1oiy]], [[1ogu]], [[1p5e]], [[1pkd]], [[1h1p]], [[1h1q]], [[1h1r]], [[1h1s]], [[4cfx]], [[4cfv]], [[4cfu]], [[4cfm]], [[5nev]], [[5nev]], [[5lmk]], [[5cyi]] - hCYCA2 +CDK2 T160P+inhibitor<br /> | + | **[[3bhu]], [[3bhv]], [[2uzd]], [[2uzb]], [[2uze]], [[2uzl]], [[2uzn]], [[2uzo]], [[2iw6]], [[2iw8]], [[2iw9]], [[2g9x]], [[1oi9]], [[1oiu]], [[1oiy]], [[1ogu]], [[1p5e]], [[1pkd]], [[1h1p]], [[1h1q]], [[1h1r]], [[1h1s]], [[4cfx]], [[4cfv]], [[4cfu]], [[4cfm]], [[5nev]], [[5nev]], [[5lmk]], [[5cyi]], [[7b7s]], [[7mkx]], [[7qhl]] - hCYCA2 +CDK2 T160P+inhibitor<br /> |
**[[1fin]], [[5if1]] - hCYCA2 +CDK2<br /> | **[[1fin]], [[5if1]] - hCYCA2 +CDK2<br /> | ||
**[[1vyw]] - hCYCA2 C-terminal 175-432 + hCDK2<br /> | **[[1vyw]] - hCYCA2 C-terminal 175-432 + hCDK2<br /> | ||
| Line 32: | Line 32: | ||
**[[1vin]] – CYCA3 - bovine<br /> | **[[1vin]] – CYCA3 - bovine<br /> | ||
**[[1e9h]] – hCYCA3 +CDK2 T160P+inhibitor<br /> | **[[1e9h]] – hCYCA3 +CDK2 T160P+inhibitor<br /> | ||
| + | **[[7sj3]] - hCYCA3 +CDK4 T160P + drug<br /> | ||
*CYCB1 or G2/mitotic-specific CYCB1 | *CYCB1 or G2/mitotic-specific CYCB1 | ||
| Line 40: | Line 41: | ||
**[[5hq0]], [[4yc3]], [[4y72]] – hCYCB1 + hCDK1 + CDK regulatory subunit 2<br /> | **[[5hq0]], [[4yc3]], [[4y72]] – hCYCB1 + hCDK1 + CDK regulatory subunit 2<br /> | ||
**[[5lqf]] – hCYCB1 + hCDK1 + CDK regulatory subunit 2 + inhibitor<br /> | **[[5lqf]] – hCYCB1 + hCDK1 + CDK regulatory subunit 2 + inhibitor<br /> | ||
| + | **[[7nj0]] – hCYCB1 + hCDK1 + CDK regulatory subunit 1 + separin – Cryo EM<br /> | ||
*CYCC | *CYCC | ||
| Line 46: | Line 48: | ||
**[[4f6s]], [[4f6u]], [[4f6w]], [[4f70]], [[4f7j]], [[4f7l]], [[4f7n]], [[4f7s]], [[5idp]], [[5idn]], [[5icp]], [[5i5z]], [[5hvy]], [[5hnb]], [[5hbj]], [[5hbh]], [[5hbe]], [[5fgk]], [[5cei]], [[5bnj]], [[5xqx]], [[5xs2]], [[6qtg]], [[6qtj]], [[6r3s]], [[6t41]] – hCYCC + CDK8 + inhibitor<br /> | **[[4f6s]], [[4f6u]], [[4f6w]], [[4f70]], [[4f7j]], [[4f7l]], [[4f7n]], [[4f7s]], [[5idp]], [[5idn]], [[5icp]], [[5i5z]], [[5hvy]], [[5hnb]], [[5hbj]], [[5hbh]], [[5hbe]], [[5fgk]], [[5cei]], [[5bnj]], [[5xqx]], [[5xs2]], [[6qtg]], [[6qtj]], [[6r3s]], [[6t41]] – hCYCC + CDK8 + inhibitor<br /> | ||
**[[6tpa]] – hCYCC + CDK8 + drug<br /> | **[[6tpa]] – hCYCC + CDK8 + drug<br /> | ||
| + | **[[7kue]] – hCYCCCL1 + TFB3 + Kin28 + ADP – Cryo EM<br /> | ||
*CYCD | *CYCD | ||
| Line 56: | Line 59: | ||
**[[1w98]] – hCYCE1 + CDK2 T160P<br /> | **[[1w98]] – hCYCE1 + CDK2 T160P<br /> | ||
| + | **[[7kjs]] – hCYCE1 + CDK2 <br /> | ||
**[[5l2w]] – hCYCE1 + CDK2 + drug<br /> | **[[5l2w]] – hCYCE1 + CDK2 + drug<br /> | ||
| Line 71: | Line 75: | ||
**[[4cxa]] - hCYCK + CDK12 T160P + AMPPNP<br /> | **[[4cxa]] - hCYCK + CDK12 T160P + AMPPNP<br /> | ||
**[[5efq]], [[4nst]] - hCYCK + CDK13 T160P + ADP<br /> | **[[5efq]], [[4nst]] - hCYCK + CDK13 T160P + ADP<br /> | ||
| + | **[[7nxj]] - hCYCK + CDK13 T160P + inhibitor<br /> | ||
**[[4un0]], [[5acb]], [[6b3e]], [[6ckx]], [[7nxj]], [[7nxk]] - hCYCK +CDK12 T160P + inhibitor<br /> | **[[4un0]], [[5acb]], [[6b3e]], [[6ckx]], [[7nxj]], [[7nxk]] - hCYCK +CDK12 T160P + inhibitor<br /> | ||
**[[6td3]] - hCYCK +CDK12 T160P+ DDB1<br /> | **[[6td3]] - hCYCK +CDK12 T160P+ DDB1<br /> | ||
| Line 83: | Line 88: | ||
**[[3lq5]], [[3tn8]], [[3tnh]], [[3tni]], [[4bcf]], [[4bcg]], [[4bch]], [[4bci]], [[4bcj]] – hCYCT1 (mutant)+CDK9<br /> | **[[3lq5]], [[3tn8]], [[3tnh]], [[3tni]], [[4bcf]], [[4bcg]], [[4bch]], [[4bci]], [[4bcj]] – hCYCT1 (mutant)+CDK9<br /> | ||
**[[3blr]] - hCYCT1 +CDK9+inhibitor<br /> | **[[3blr]] - hCYCT1 +CDK9+inhibitor<br /> | ||
| - | **[[6gzh]], [[6z45]] - hCYCT1 TPO160 +CDK9+inhibitor<br /> | + | **[[6gzh]], [[6z45]], [[7nwk]] - hCYCT1 TPO160 +CDK9+inhibitor<br /> |
**[[3my1]], [[4ec8]], [[4ec9]] - hCYCT1 (mutant)+CDK9 TPO160 +inhibitor<br /> | **[[3my1]], [[4ec8]], [[4ec9]] - hCYCT1 (mutant)+CDK9 TPO160 +inhibitor<br /> | ||
**[[3mi9]], [[3mia]] - hCYCT1 +CDK9+protein TAT<br /> | **[[3mi9]], [[3mia]] - hCYCT1 +CDK9+protein TAT<br /> | ||
Revision as of 10:18, 4 December 2022
3D Structures of Cyclin
Updated on 04-December-2022
